Back to Search Start Over

Fine mapping of a region of chromosome 11q13 reveals multiple independent loci associated with risk of prostate cancer

Authors :
Geraldine Cancel-Tassin
W. Ryan Diver
Laurence N. Kolonel
Nilanjan Chatterjee
Jarmo Virtamo
Quan Chen
Richard B. Hayes
Joseph F. Fraumeni
Olivier Cussenot
Brian E. Henderson
Amy Hutchinson
Elio Riboli
Charles C. Chung
Daniela S. Gerhard
David J. Hunter
Christopher A. Haiman
Gilles Thomas
Rudolf Kaaks
Nick Orr
Loic Le Marchand
Stephanie J. Weinstein
William B. Isaacs
Sonja I. Berndt
Julia Ciampa
E. David Crawford
Lars J. Vatten
Stephen J. Chanock
Peter Kraft
Inger Njølstad
Afshan Siddiq
Kevin B. Jacobs
Gerald L. Andriole
Heather Spencer Feigelson
Sarah D. Isaacs
Sholom Wacholder
Jesus Gonzalez-Bosquet
Timothy J. Key
Meredith Yeager
Henrik Grönberg
Margaret A. Tucker
Demetrius Albanes
Robert N. Hoover
Fredrik Wiklund
Antoine Valeri
Jianfeng Xu
Kai Yu
Kristian Hveem
Michael J. Thun
Fredrick R. Schumacher
Joseph Boland
Clinical Genetics Branch, Division of Cancer Epidemiology & Genetics
National Institutes of Health [Bethesda] (NIH)-National Cancer Institute [Bethesda] (NCI-NIH)
National Institutes of Health [Bethesda] (NIH)
Department of Epidemiology
Harvard School of Public Health
institute for health research
Division of Cancer Epidemiology and Genetics
National Cancer Institute [Bethesda] (NCI-NIH)
National Institutes of Health [Bethesda] (NIH)-National Institutes of Health [Bethesda] (NIH)
Department of Chronic Disease Prevention
National Institute for Health and Welfare [Helsinki]
Centre de Recherche pour les Pathologies Prostatiques. (CeRePP / UA 3104)
CEREPP
Commissariat à l'énergie atomique et aux énergies alternatives (CEA)
Service d'urologie
Université de Brest (UBO)-Centre Hospitalier Régional Universitaire de Brest (CHRU Brest)
University of Hawai‘i [Mānoa] (UHM)
Department of Genomics of Common Disease
Imperial College London-School of public health
The University of Hong Kong (HKU)-The University of Hong Kong (HKU)
Department of Epidemiology and Biostatistics
Imperial College London-Faculty of Medicine-School of public health
Department of Epidemiology and Public Health
Imperial College London
Radcliffe Infirmary
Cancer Research UK
Cancer Research UK Epidemiology Unit
University of Oxford [Oxford]
Division of Cancer Epidemiology
German Cancer Research Center - Deutsches Krebsforschungszentrum [Heidelberg] (DKFZ)
Department of Medical Epidemiology and Biostatistics (MEB)
Karolinska Institutet [Stockholm]
DURHAM
Durham
Equipe 6
Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL)
Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL)
Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL)
Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Division of Cancer Epidemiology and Genetics
National Institutes of Health [Bethesda] (NIH)-National Institutes of Health [Bethesda] (NIH)-National Cancer Institute [Bethesda] (NCI-NIH)
Pediatric Oncology Branch
University of Oxford
Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)
Source :
Human Molecular Genetics, Human Molecular Genetics, Oxford University Press (OUP), 2011, 20 (14), pp.2869-78. ⟨10.1093/hmg/ddr189⟩, Human Molecular Genetics, 2011, 20 (14), pp.2869-78. ⟨10.1093/hmg/ddr189⟩
Publication Year :
2011
Publisher :
Oxford University Press (OUP), 2011.

Abstract

International audience; Genome-wide association studies have identified prostate cancer susceptibility alleles on chromosome 11q13. As part of the Cancer Genetic Markers of Susceptibility (CGEMS) Initiative, the region flanking the most significant marker, rs10896449, was fine mapped in 10 272 cases and 9123 controls of European origin (10 studies) using 120 common single nucleotide polymorphisms (SNPs) selected by a two-staged tagging strategy using HapMap SNPs. Single-locus analysis identified 18 SNPs below genome-wide significance (P< 10(-8)) with rs10896449 the most significant (P= 7.94 × 10(-19)). Multi-locus models that included significant SNPs sequentially identified a second association at rs12793759 [odds ratio (OR) = 1.14, P= 4.76 × 10(-5), adjusted P= 0.004] that is independent of rs10896449 and remained significant after adjustment for multiple testing within the region. rs10896438, a proxy of previously reported rs12418451 (r(2)= 0.96), independent of both rs10896449 and rs12793759 was detected (OR = 1.07, P= 5.92 × 10(-3), adjusted P= 0.054). Our observation of a recombination hotspot that separates rs10896438 from rs10896449 and rs12793759, and low linkage disequilibrium (rs10896449-rs12793759, r(2)= 0.17; rs10896449-rs10896438, r(2)= 0.10; rs12793759-rs10896438, r(2)= 0.12) corroborate our finding of three independent signals. By analysis of tagged SNPs across ∼123 kb using next generation sequencing of 63 controls of European origin, 1000 Genome and HapMap data, we observed multiple surrogates for the three independent signals marked by rs10896449 (n= 31), rs10896438 (n= 24) and rs12793759 (n= 8). Our results indicate that a complex architecture underlying the common variants contributing to prostate cancer risk at 11q13. We estimate that at least 63 common variants should be considered in future studies designed to investigate the biological basis of the multiple association signals.

Details

ISSN :
14602083, 09646906, and 10896449
Volume :
20
Database :
OpenAIRE
Journal :
Human Molecular Genetics
Accession number :
edsair.doi.dedup.....a96d8c15b1730de65407171074ae3b08
Full Text :
https://doi.org/10.1093/hmg/ddr189